PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

SEGALL BRYANT & HAMILL, LLC's Holding History (CIK: 0001006378)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 129,060 Value ($000) $11,272 Avg Close $81.85 Range $62.24 - $96.54

Q3 2025

Shares 123,125 Value ($000) $8,179 Avg Close $56.84 Range $49.38 - $68.26

Q2 2025

Shares 120,159 Value ($000) $6,641 Avg Close $47.99 Range $39.60 - $57.70

Q3 2024

Shares 120,301 Value ($000) $5,414 Avg Close $40.40 Range $32.50 - $48.00

Q2 2024

Shares 118,562 Value ($000) $4,108 Avg Close $29.29 Range $24.22 - $35.96

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	129,060	$11,272	$81.85	$62.24 - $96.54
Q3 2025	123,125	$8,179	$56.84	$49.38 - $68.26
Q2 2025	120,159	$6,641	$47.99	$39.60 - $57.70
Q3 2024	120,301	$5,414	$40.40	$32.50 - $48.00
Q2 2024	118,562	$4,108	$29.29	$24.22 - $35.96